Processa Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PCSA and other ETFs, options, and stocks.

About PCSA

Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. Its main product candidate is PCS499, which is intended for the treatment of Necrobiosis Lipoidica.

CEO

George K. Ng

CEOGeorge K. Ng

Employees

Employees10

Headquarters

Hanover, Maryland

HeadquartersHanover, Maryland

Founded

2011

Founded2011

Employees

Employees10

PCSA Key Statistics

Market cap

5.34M

Market cap5.34M

Price-Earnings ratio

-0.07

Price-Earnings ratio-0.07

Dividend yield

—

Dividend yield—

Average volume

11.80M

Average volume11.80M

High today

$0.2198

High today$0.2198

Low today

$0.201

Low today$0.201

Open price

$0.21

Open price$0.21

Volume

4.63M

Volume4.63M

52 Week high

$3.10

52 Week high$3.10

52 Week low

$0.15

52 Week low$0.15

People also own

Based on the portfolios of people who own PCSA. This list is generated using Robinhood data, and it’s not a recommendation.